Articles related to VISION LOSS

Vigabatrin can cause irreversible peripheral retinal toxicity that is often asymptomatic, underscoring the need for consistent ophthalmic monitoring in treated patients.

“The increased risk of NAION with Wegovy is due to the higher dosage of semaglutide…the difference between the two dosages and the rates of NAION may indicate a dose-dependent increase in risk.” – Benjamin Bert, MD

More than 80% of the patients were able to read letters and words, and some of them are reading pages in a book.

Patients taking semaglutide for diabetes were more than four times more likely to develop NAION compared to those on other diabetes medications, while those using it for obesity had a seven-fold increased risk.

In a recent study, color Doppler ultrasound identified Giant Cell Arteritis in 44% of suspected cases, proving its effectiveness as a first-line diagnostic tool. This method offers a significant advantage in managing patient care by potentially reducing the need for subsequent invasive testing.

A groundbreaking study in The Lancet Neurology reports that 94% of patients with posterior cortical atrophy also have Alzheimer’s disease pathology, stressing the need for heightened awareness among clinicians for earlier diagnosis and intervention.